Racial/ethnic variation found in nasal gene expression of key protein used by SARS-CoV-2

Credit: CC0 Public Domain

In a study published in JAMA today, Mount Sinai researchers report findings that shed some light on the disproportionate impact of COVID-19 on Blacks, who have experienced rates of infection and death that are much greater, in some areas twice and three times more, than their proportion of the population. "Our study suggests one factor that may partially contribute to COVID-19 risk among Blacks," says lead author, Supinda Bunyavanich, MD, MPH, Professor of Genetics & Genomic Sciences and Pediatrics, Icahn School of Medicine at Mount Sinai.

"The virus that causes COVID-19, SARS-Cov-2, uses transmembrane serine protease 2 (TMPRSS2) to facilitate entry and spread in the body," says Dr. Bunyavanich. "The degree to which a person expresses TMPRSS2 may affect how easy it is for the virus to get in and spread. We found that nasal expression of TMPRSS2 was significantly higher in Blacks than in Asians, Latinos, those of mixed race/ethnicity, and Whites. An important point is that is a dynamic reflection of personal, social, and environmental history, and many complex factors contribute to health disparities."

In this retrospective analysis, Dr. Bunyavanich and colleagues drew on a cross-sectional study of 305 patients of diverse racial/ethnic backgrounds, ages 4-60, within the Mount Sinai Health System, from whom they collected nasal samples.

"One of the key takeaways of our findings is the critical importance of including diverse participants in ," says Dr. Bunyavanich. "In clinical trials of TMPRSS2 inhibitors, it's possible that different effects may be seen depending on racial/ethnic background. More broadly, we also need to address the social determinants of health, economic disparities, and differential access to health care that drive racial/ethnic disparities in health."

In a previous study, also published in JAMA, Dr. Bunyavanich and colleagues studied the same cohort to better understand why COVID-19 may be less common among children. "In that study, we found age-dependent expression of the SARS-CoV-2 receptor angiotensin converting enzyme 2 (ACE2) in nasal epithelium, with levels lowest in young children and increasing with age into adulthood. Lower ACE2 expression may help explain why children have been largely spared in the pandemic, while possibly pointing to a potential biomarker of susceptibility to SARS-CoV-2," says Dr. Bunyavanich.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: Supinda Bunyavanich et al, Racial/Ethnic Variation in Nasal Gene Expression of Transmembrane Serine Protease 2 (TMPRSS2), JAMA (2020). DOI: 10.1001/jama.2020.17386
Citation: Racial/ethnic variation found in nasal gene expression of key protein used by SARS-CoV-2 (2020, September 10) retrieved 22 September 2020 from https://medicalxpress.com/news/2020-09-racialethnic-variation-nasal-gene-key.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments